Publications by authors named "Elizabeth Dawn Flick"
Article Synopsis
- The study investigates the frequency of ring sideroblasts (RS) and SF3B1 gene mutation testing in lower-risk myelodysplastic syndromes (MDS) before and after the 2016 WHO classification criteria were published.
- Out of 489 LR-MDS patients, a high percentage underwent RS assessment, but a low percentage of those with less than 15% RS were tested for SF3B1 mutations, indicating a gap in testing practices.
- No significant change in RS assessment rates was observed post-publication of WHO guidelines, highlighting a need for improved education on the importance of genetic testing in these patients.
Background: Studies have reported racial disparities in access to and use of multiple myeloma (MM) treatments between African American (AA) and White patients. Although AA patients demonstrate longer disease-specific survival, this has not uniformly translated into improved survival over time. The association between race and treatment patterns and survival outcomes was analyzed using data from the Connect MM Registry.
View Article and Find Full Text PDF